Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Microbial Drug Resistance
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2023-05-17
DOI
10.1089/mdr.2022.0248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
- (2021) Jae-Min Park et al. Antibiotics-Basel
- Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant Acinetobacter baumannii
- (2020) Ben Liu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
- (2019) Tianshui Niu et al. Antimicrobial Resistance and Infection Control
- Carbapenem-resistant Acinetobacterbaumannii: in pursuitof an effective treatment
- (2019) Evangelia-Theophano Piperaki et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery
- (2019) Sajjad Ahmad et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
- (2019) Yangang Zhou et al. BMC Pharmacology & Toxicology
- Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis
- (2019) Hekun Mei et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extensive drug resistant Acinetobacter baumannii: a comparative study between non-colistin based combinations
- (2019) Eman Elsayed et al. International Journal of Clinical Pharmacy
- Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii
- (2018) C.-A. Liang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study
- (2018) Oguz Reşat Sipahi et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii
- (2018) Youfa Qin et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates
- (2018) Shio-Shin Jean et al. MEDICINE
- Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2017) Kirati Kengkla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A novel genome editing platform for drug resistantAcinetobacter baumanniirevealed an AdeR-unrelated tigecycline resistance mechanism
- (2016) Vincent Trebosc et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
- (2016) Jung-Jr Ye et al. BMC INFECTIOUS DISEASES
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
- (2016) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
- (2016) Shio-Shin Jean et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii
- (2016) Hangyong He et al. Journal of Thoracic Disease
- Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
- (2016) Won-Young Kim et al. PLoS One
- Efficacy of Tigecycline for Secondary Acinetobacter Bacteremia and Factors Associated with Treatment Failure
- (2015) Bo-Huang Liou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2015) Aristine Cheng et al. CRITICAL CARE MEDICINE
- Colistin–tigecycline versus colistin–imipenem–cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study
- (2015) Anis Chaari et al. INTENSIVE CARE MEDICINE
- Global Assessment of Antimicrobial Susceptibility among Gram-Negative Organisms Collected from Pediatric Patients between 2004 and 2012: Results from the Tigecycline Evaluation and Surveillance Trial
- (2015) Sue C. Kehl et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficacy and Safety Profile Comparison of Colistin and Tigecycline on the Extensively Drug Resistant Acinetobacter baumannii
- (2014) Sung Hee Kwon et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis
- (2014) Yu-Chung Chuang et al. BMC INFECTIOUS DISEASES
- Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
- (2014) Thana Khawcharoenporn et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Late Onset Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter spp.: Experience with Tigecycline
- (2014) D. Curcio et al. JOURNAL OF CHEMOTHERAPY
- Clinical Experience with Tigecycline in the Treatment of Carbapenem-ResistantAcinetobacterInfections
- (2014) G. Metan et al. JOURNAL OF CHEMOTHERAPY
- In vitroactivity of tigecycline and colistin againstA. baumanniiclinical bloodstream isolates during an 8-year period
- (2014) Anastasia Spiliopoulou et al. JOURNAL OF CHEMOTHERAPY
- Risk Factors for Healthcare-Associated Extensively Drug-Resistant Acinetobacter baumannii Infections: A Case-Control Study
- (2014) Ming-Chin Chan et al. PLoS One
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
- (2013) Y.-T. Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital
- (2013) V. Avkan-Oguz et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
- (2013) Wentao Ni et al. JOURNAL OF ANTIBIOTICS
- The value of single-pathogen antibacterial agents
- (2013) Brad Spellberg et al. NATURE REVIEWS DRUG DISCOVERY
- Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections
- (2012) Kimberly Ku et al. AMERICAN JOURNAL OF INFECTION CONTROL
- The emergence of clinical resistance to tigecycline
- (2012) Yan Sun et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical Experience of Tigecycline Treatment in Infections Caused by Extensively Drug-Resistant Acinetobacter spp.
- (2012) Soo-Youn Moon et al. Microbial Drug Resistance
- Clinical Outcomes of Tigecycline in the Treatment of Multidrug-ResistantAcinetobacter baumanniiInfection
- (2012) Jung Ar Shin et al. YONSEI MEDICAL JOURNAL
- Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy
- (2011) R. Guner et al. INFECTION
- The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
- (2011) Jung-Jr Ye et al. JOURNAL OF INFECTION
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
- (2010) Yun Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Off-label use of antibiotics in hospitalized patients: focus on tigecycline
- (2009) D. Curcio JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
- (2009) N. C. Gordon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry
- (2008) Daniel Curcio et al. Brazilian Journal of Infectious Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now